Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|October 12, 2005
Betaine improved restriction digestionKeiki Sugimoto, Tohru Makihara, Aya Saito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
B cell receptor-ERK1/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiationTakahiko Yasuda, Fumihiko Hayakawa, Shingo Kurahashi, et al.
Experimental Lung Research|January 29, 2011
Suppression of transforming growth factor β1 in lung alveolar epithelium-derived cells using adeno-associated virus type 2/5 vectors to carry short hairpin RNAHidenori Kage, Keiki Sugimoto, Atsushi Sano, et al.
Biochemical and Biophysical Research Communications|June 5, 2007
The induction of H3K9 methylation by PIWIL4 at the p16Ink4a locusKeiki Sugimoto, Hidenori Kage, Naomi Aki, et al.
Scientific Reports|August 18, 2015
Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cellsKeiki Sugimoto, Fumihiko Hayakawa, Satoko Shimada, et al.
The Journal of Organic Chemistry|July 1, 2006
Shapes of antibody binding sites: qualitative and quantitative analyses based on a geomorphic classification schemeMichelle Lee, Peter Lloyd, Xiyun Zhang, et al.
Oncotarget|August 6, 2016
The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinibTakanobu Morishita, Fumihiko Hayakawa, Keiki Sugimoto, et al.
The Journal of Biological Chemistry|December 26, 2015
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic LeukemiaNaoto Imoto, Fumihiko Hayakawa, Shingo Kurahashi, et al.
Pharmacological Research|April 12, 2017
YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphomaYuki Kojima, Fumihiko Hayakawa, Takanobu Morishita, et al.
Scientific Reports|August 3, 2016
Fibroblast Growth Factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functionsKeiki Sugimoto, Yasuhiko Miyata, Takayuki Nakayama, et al.
Pageof 2